THRIVENT FINANCIAL FOR LUTHERANS - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
THRIVENT FINANCIAL FOR LUTHERANS ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$76,485
+1043.3%
630,961
+980.0%
0.18%
+1113.3%
Q2 2023$6,690
-91.6%
58,424
-89.8%
0.02%
-92.2%
Q1 2023$79,323
-13.3%
575,519
-18.5%
0.19%
-18.6%
Q4 2022$91,496
-99.9%
706,102
+0.9%
0.24%
+11.8%
Q3 2022$77,321,000
+798.4%
699,483
+509.2%
0.21%
+821.7%
Q2 2022$8,607,000
-7.3%
114,829
-3.4%
0.02%
+27.8%
Q1 2022$9,288,000
-15.2%
118,893
-2.3%
0.02%
-14.3%
Q4 2021$10,954,000
+13.5%
121,649
+16.5%
0.02%
+5.0%
Q3 2021$9,653,000
+19.2%
104,383
+0.2%
0.02%
+25.0%
Q2 2021$8,097,000
+141.2%
104,155
+131.2%
0.02%
+128.6%
Q1 2021$3,357,000
-64.3%
45,044
-18.3%
0.01%
-68.2%
Q4 2020$9,405,000
+46.6%
55,161
+20.7%
0.02%
+29.4%
Q3 2020$6,417,000
-14.6%
45,696
-2.5%
0.02%
-22.7%
Q2 2020$7,518,000
+64.6%
46,889
+0.4%
0.02%
+37.5%
Q1 2020$4,568,000
-23.9%
46,699
+0.4%
0.02%
-5.9%
Q4 2019$6,001,000
+118.5%
46,503
+27.5%
0.02%
+88.9%
Q3 2019$2,746,000
+448.1%
36,462
+305.1%
0.01%
+350.0%
Q4 2017$501,000
+27.2%
9,000
-31.9%
0.00%0.0%
Q2 2014$394,00013,2100.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders